CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-18 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +7,500 | $0.03 | $248 | 763,989 |
| 2020-05-18 | Kauffman Michael Chief Executive Officer | Sale | −7,500 | $20.00 | $150K | 756,489 |
| 2020-05-18 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,500 | 357 | ||
| 2020-05-18 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $0.03 | $248 | 763,989 |
| 2020-05-18 | Shacham Sharon President & CSO | Sale | −7,500 | $20.00 | $150K | 756,489 |
| 2020-05-18 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −7,500 | 357 | ||
| 2020-05-15 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +7,500 | $0.03 | $248 | 763,989 |
| 2020-05-15 | Kauffman Michael Chief Executive Officer | Sale | −7,500 | $18.65 | $140K | 756,489 |
| 2020-05-15 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,500 | 7,857 | ||
| 2020-05-15 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $0.03 | $248 | 763,989 |
| 2020-05-15 | Shacham Sharon President & CSO | Sale | −7,500 | $18.65 | $140K | 756,489 |
| 2020-05-15 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −7,500 | 7,857 | ||
| 2020-05-07 | Frenkel Ran Chief Dev Operations Officer | Sale | −1,974 | $20.00 | $39K | 35,088 |
| 2020-05-07 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −6,714 | $19.62 | $132K | 4,649 |
| 2020-05-07 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion | +2,946 | $6.54 | $19K | 7,595 |
| 2020-05-07 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Sale | −2,946 | $20.00 | $59K | 4,649 |
| 2020-05-07 | Primiano Christopher Brett EVP, CBO, GC & Secretary | Exercise or conversion · Stock Option (right to buy) | −2,946 | 10,054 | ||
| 2020-05-07 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $4.75 | $36K | 763,989 |
| 2020-05-07 | Shacham Sharon President & CSO | Sale | −7,500 | $19.63 | $147K | 756,489 |
| 2020-05-07 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $4.75 | $36K | 562,622 |
Page 25 of 29 · 570 trades